New Key Statistics Module, Z-Score and F-Score
NAS:JANX Key Ratios
Market Cap $ M | 2,463.43 |
Enterprise Value $ M | 1,834.29 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 3.75 |
Price/Sales | 298.62 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 7.00 |
EPS (TTM) $ | -1.21 |
Beneish M-Score | 3.01 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -25.18 |
EV-to-EBITDA | -25.90 |
PEG | -- |
Shares Outstanding M | 51.85 |
Net Margin (%) | -762.92 |
Operating Margin % | -999.85 |
Pre-tax Margin (%) | -762.92 |
Quick Ratio | 62.09 |
Current Ratio | 62.09 |
ROA % (ttm) | -12.92 |
ROE % (ttm) | -14.18 |
ROIC % (ttm) | -190.78 |
Dividend Yield % | -- |
Altman Z-Score | 44.96 |
JANX Number of Guru Trades
JANX Volume of Guru Trades
Gurus Latest Trades with NAS:JANX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:JANX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Janux Therapeutics Inc Insider Transactions
No Available Data
News about NAS:JANX
Total 0- 1